Dongwoon Anatech

Screenshots of Dongwoon Anatech's blood glucose monitoring device.
South Korean chipmaker bats US FDA approval of its non-invasive glucose monitoring device
By Thiru Gunasegaran | 03:40 am | April 12, 2021
The semiconductor player claims success with D-SaLife in a recent clinical trial involving diabetic outpatients.